Heterologous prime-boost vaccination against H5 avian influenza: Safety and immunogenicity of a MF59-adjuvanted, cell-culture derived H5N6 vaccine.
Authors: Van Twuijver E, Versage E, Jacobs RL, Hohenboken M
Journal: Human vaccines & immunotherapeutics
acceptance commitment therapy
mental health
open access